Biodesix, Inc. (BDSX)
NASDAQ: BDSX · IEX Real-Time Price · USD
1.250
+0.010 (0.81%)
At close: May 1, 2024, 4:00 PM
1.400
+0.150 (12.00%)
After-hours: May 1, 2024, 7:17 PM EDT

Biodesix Revenue

In the year 2023, Biodesix had annual revenue of $49.09M with 28.46% growth. Revenue in the quarter ending December 31, 2023 was $14.67M with 52.68% year-over-year growth.

Revenue (ttm)
$49.09M
Revenue Growth
+28.46%
P/S Ratio
2.92
Revenue / Employee
$226,207
Employees
217
Market Cap
143.19M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202349.09M10.88M28.46%
Dec 31, 202238.21M-16.29M-29.89%
Dec 31, 202154.51M8.95M19.64%
Dec 31, 202045.56M21.01M85.55%
Dec 31, 201924.55M4.12M20.16%
Dec 31, 201820.43M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
P3 Health Partners 1.27B
High Tide 497.66M
Seres Therapeutics 126.33M
Electromed 51.69M
Augmedix 44.86M
ClearPoint Neuro 23.96M
Syros Pharmaceuticals 9.94M
MSP Recovery 7.71M
Revenue Rankings